HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The usefulness of transcatheter arterial embolization for patients with blunt polytrauma showing transient response to fluid resuscitation.

AbstractBACKGROUND:
This study aimed to determine whether nonsurgical management using transcatheter arterial embolization (TAE) is safe for patients with blunt multiple trauma who transiently respond to the initial fluid resuscitation.
METHODS:
Contrast computed tomography was performed for patients with blunt abdominal injuries, excluding those who did not respond to initial fluid resuscitation. Angiography was performed for patients with injuries showing contrast extravasation or solid organ injury classified, according to the American Association for the Surgery of Trauma, as grade 3 or higher on computed tomography. Transcatheter arterial embolization was performed when angiography showed arterial extravasation. The protocol was abandoned for any patients who became profoundly hypotensive (with systolic blood pressure 60 mm Hg or lower) during computed tomography or angiography.
RESULTS:
Between January 2000 and December 2002, 269 patients with blunt abdominal injuries underwent TAE immediately after admission. Of these patients, 41 had injuries in at least two regions and underwent TAE for these regions. Among them, 22 patients were hemodynamically stable or showed rapid response to fluid resuscitation. The nonsurgical treatment was successful in all these cases. The remaining 19 patients (Injury Severity Score, 37.3 +/- 8.2), who showed a transient response, were the subjects of this study. Of these patients, 15 underwent TAE for injuries in two regions (13 pelvic fractures, 7 splenic injuries, 6 hepatic injuries, 3 facial bleeding, and 1 renal injury), and 4 patients underwent TAE for injuries in three regions (4 had splenic injuries, 3 hepatic injuries, 2 renal injuries, 2 pelvic fractures, and 1 facial bleeding). For all these patients, TAE was successfully performed. Before TAE, the systolic blood pressure was 79.9 +/- 8.4 mm Hg, and the shock index was 1.45 +/- 0.25 mm Hg. After TAE, the corresponding values were 120.6 +/- 19.3 mm Hg and 0.87 +/- 0.16 mm Hg, respectively (p < 0.001). The rate of fluid administration required after TAE (214.2 +/- 139.3 mL/hour) was significantly less than that required before TAE (1244.2 +/- 347.1 mL/hour; range, 632-1,728 mL/hour) (p < 0.001). The deaths of two patients were classified as nonpreventable on the basis of the Trauma and Injury Severity Score (TRISS), and their respective probabilities of survival were determined to be 0.13 and 0.03.
CONCLUSION:
Nonsurgical management using TAE can be performed safely even for patients with blunt multiple trauma who are in hemorrhagic hypotension if their hemodynamics are improved by resuscitation with 2 L of fluid.
AuthorsAkiyoshi Hagiwara, Atsuo Murata, Takeaki Matsuda, Hiroharu Matsuda, Shuji Shimazaki
JournalThe Journal of trauma (J Trauma) Vol. 57 Issue 2 Pg. 271-6; discussion 276-7 (Aug 2004) ISSN: 0022-5282 [Print] United States
PMID15345972 (Publication Type: Journal Article)
Topics
  • Abdominal Injuries (complications, diagnosis)
  • Adolescent
  • Adult
  • Aged
  • Angiography (standards)
  • Arteries (injuries)
  • Child
  • Embolization, Therapeutic (instrumentation, methods)
  • Extravasation of Diagnostic and Therapeutic Materials (etiology)
  • Female
  • Fluid Therapy (methods)
  • Follow-Up Studies
  • Hemorrhage (etiology, prevention & control)
  • Humans
  • Hypotension (etiology, prevention & control)
  • Injury Severity Score
  • Male
  • Middle Aged
  • Multiple Trauma (complications, diagnosis)
  • Patient Selection
  • Safety
  • Sensitivity and Specificity
  • Survival Analysis
  • Tomography, X-Ray Computed (standards)
  • Treatment Outcome
  • Wounds, Nonpenetrating (complications, diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: